MLICM
IRON icon

Metropolitan Life Insurance Company (MetLife)’s Disc Medicine IRON Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-529
Closed -$32.9K – 1059
2024
Q1 		$32.9K Hold
529
– – ﹤0.01% 1613
2023
Q4 		$30.6K Hold
529
– – ﹤0.01% 1710
2023
Q3 		$24.9K Buy
529
+94
+22% +$4.7K ﹤0.01% 1787
2023
Q2 		$19.3K Buy
+435
New +$15.4K ﹤0.01% 1949

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IRON Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 529 shares — an estimated $32.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IRON in Q2 2023 and held it in 4 quarters. The position peaked at $32.9K in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 529 Disc Medicine shares in Q2 2024, an estimated $32.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Disc Medicine in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Disc Medicine position peaked at $32.9K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.